HORIZON PHARMA INC's ticker is HZNP and the CUSIP is 44047T109. A total of 68 filers reported holding HORIZON PHARMA INC in Q3 2013. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $3,164,000 | -84.0% | 200,000 | -84.7% | 0.07% | -87.1% |
| Q1 2014 | $19,773,000 | +205.3% | 1,307,760 | +53.9% | 0.54% | +112.1% |
| Q4 2013 | $6,477,000 | +127.4% | 850,000 | 0.0% | 0.26% | +120.7% |
| Q3 2013 | $2,848,000 | -6.2% | 850,000 | -31.2% | 0.12% | -22.1% |
| Q2 2013 | $3,037,000 | – | 1,234,693 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 5,815,940 | $18,012,000 | 11.89% |
| Murphy Michael R | 6,244,246 | $20,918,000 | 8.67% |
| Beach Point Capital Management LP | 1,881,578 | $6,303,000 | 1.91% |
| Broadfin Capital, LLC | 1,880,000 | $6,298,000 | 1.12% |
| GREAT POINT PARTNERS LLC | 100,000 | $335,000 | 0.23% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,173,728 | $3,955,000 | 0.19% |
| J. Goldman & Co LP | 562,050 | $1,883,000 | 0.18% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,223,071 | $7,447,000 | 0.15% |
| Alyeska Investment Group, L.P. | 850,000 | $2,848,000 | 0.12% |
| Consonance Capital Management LP | 105,000 | $352,000 | 0.09% |